Development of an immunoblot assay with infrared fluorescence to quantify paraoxonase 1 in serum and plasma
Open Access
- 1 January 2008
- journal article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 49 (1), 245-250
- https://doi.org/10.1194/jlr.d700022-jlr200
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- TagSNP analyses of the PON gene cluster: effects on PON1 activity, LDL oxidative susceptibility, and vascular diseaseJournal of Lipid Research, 2006
- The paraoxonase gene family and atherosclerosisFree Radical Biology & Medicine, 2005
- Low Paraoxonase Activity Predicts Coronary Events in the Caerphilly Prospective StudyCirculation, 2003
- Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controlsEuropean Journal of Clinical Investigation, 2002
- Serum Paraoxonase (PON1) Concentration in Patients Undergoing Hemodialysis.Journal of Atherosclerosis and Thrombosis, 2002
- Paraoxonase Status in Coronary Heart DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Effects of 5′ Regulatory-Region Polymorphisms on Paraoxonase-Gene (PON1) ExpressionAmerican Journal of Human Genetics, 2001
- Low paraoxonase activity in type II diabetes mellitus complicated by retinopathyClinical Science, 2000
- Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.JCI Insight, 1997
- Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and LipoproteinsArteriosclerosis, Thrombosis, and Vascular Biology, 1995